IGC Pharma(DE:IGS1)
€0.18+0.00 (+7.98%)
DE:IGS1
IGC Pharma Revenue
€0.18
At close:+0.00 (+7.98%)
IGC Pharma (IGS1) Revenue
6 Followers
IGC Pharma Revenue
IGC Pharma had a revenue of 328.00K in the quarter ending Sep 30, 2026, with 23.77%. This bring the company's revenue in the last twelve months to 1.26M, Increased 12.20%. In the fiscal year ending Mar 31, 2026, IGC Pharma had annual revenue of 1.19M with -6.69% growth.
- Revenue (ttm)
- 1.26M
- Revenue Growth
- ―
- P/S Ratio
- 17.27
- Revenue/Employee
- EUR 16,943
- Employees
- 70
- Market Cap
- EUR 20.48M
Revenue Chart
IGC Pharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.19M | -85.00K | -6.69% |
| Mar 31, 2025 | 1.27M | -74.00K | -5.50% |
| Mar 31, 2024 | 1.34M | 434.00K | 47.64% |
| Jun 30, 2023 | 911.00K | 514.00K | 129.47% |
| Mar 31, 2022 | 397.00K | -501.00K | -55.79% |
| Mar 31, 2021 | 898.00K | -3.17M | -77.95% |
| Mar 31, 2020 | 4.07M | -1.04M | -20.41% |
| Mar 31, 2019 | 5.12M | 2.92M | 133.29% |
| Mar 31, 2018 | 2.19M | 1.61M | 277.86% |
| Mar 31, 2017 | 580.37K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.